1β-hydroxyl-5α-chloro-8-epi-xanthatin Suppresses Inflammatory Responses by Targeting IKKα/β and Inhibiting the NF-κB Signaling Pathway
Journal of Visualized Experiments · 2026
DOI: 10.3791/71253 ↗At a glance
Video/Audio in Journal of Visualized Experiments, 2026. Written by Hai Zhang and 4 co-authors. Institution: College of Pharmacy, Chinese Medicine Germplasm Resources Innovation and Effective Uses Key Laboratory of Sichuan Province, Chengdu University of Tra…. Major MEDLINE topics: I-kappa B Kinase, NF-kappa B, Furans, Anti-Inflammatory Agents.
Abstract (original language)
Dysregulation of the nuclear factor-κB (NF-κB) cascade is tightly linked to the progression of inflammatory disorders. IκB kinases (IKKs) are well-established as central modulators of NF-κB activity, making them attractive therapeutic candidates for treating inflammatory pathologies. The sesquiterpene lactone 1β-hydroxyl-5α-chloro-8-epi-xanthatin (XTT) has been documented to exert robust anticancer effects. However, its anti-inflammatory activity and underlying molecular mechanisms remain unclear. In this work, XTT markedly suppressed the synthesis of nitric oxide (NO) and prostaglandin E2 (PGE2) in lipopolysaccharide (LPS)-activated RAW264.7 macrophages. XTT also substantially lowered LPS-triggered mRNA levels of inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX2), tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), and interleukin-6 (IL-6). Furthermore, XTT downregulated the protein levels of iNOS and COX2 elicited by LPS treatment. At the mechanistic level, XTT did not notably alter the activity of the mitogen-activated protein kinase (MAPK) cascade. Conversely, XTT strongly blocked LPS-triggered phosphorylation and breakdown of inhibitory κBα (IκBα) by interacting with IKKα/β, thus impairing NF-κB nuclear translocation. Taken together, these data show that XTT elicits robust anti-inflammatory effects in vitro via targeting IKKα/β and blocking NF-κB signaling. These results suggest that XTT may serve as a promising lead compound for the development of anti-inflammatory agents. Further biochemical and in vivo studies are required to validate direct IKKα/β inhibition and therapeutic potential.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- College of Pharmacy, Chinese Medicine Germplasm Resources Innovation and Effective Uses Key Laboratory of Sichuan Province, Chengdu University of Traditional Chinese Medicine.
- Center for Natural Products Research, Chengdu Institute of Biology, Chinese Academy of Sciences.
- Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu University of Traditional Chinese Medicine; xiaofeishen@cdutcm.edu.cn.
Cite
APA
Zhang, H., Liu, X., Song, G., Wang, L., & Shen, X. (2026). 1β-hydroxyl-5α-chloro-8-epi-xanthatin Suppresses Inflammatory Responses by Targeting IKKα/β and Inhibiting the NF-κB Signaling Pathway. Journal of Visualized Experiments. https://doi.org/10.3791/71253
Vancouver
Zhang H, Liu X, Song G, Wang L, Shen X. 1β-hydroxyl-5α-chloro-8-epi-xanthatin Suppresses Inflammatory Responses by Targeting IKKα/β and Inhibiting the NF-κB Signaling Pathway. Journal of Visualized Experiments. 2026. doi:10.3791/71253
BibTeX
@article{Zhang2026,
author = {Zhang, Hai and Liu, Xiaofang and Song, Guangyu and Wang, Lun and Shen, Xiaofei},
title = {1β-hydroxyl-5α-chloro-8-epi-xanthatin Suppresses Inflammatory Responses by Targeting IKKα/β and Inhibiting the NF-κB Signaling Pathway},
journal = {Journal of Visualized Experiments},
year = {2026},
doi = {10.3791/71253}
}
EUVIMED